Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Sarcoma
Study Phase
Phase 3
Study Completion Date
September 2012
NCT00075582Uploaded 11-11-2020
Access via NCI by Request
PDS UID: nci-data-436
Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients With Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma
Files: NCT00075582-D1
Data DictionaryNCT00075582-D1-Data-Dictionary_4.pdf
DATANCT00075582-D1-Dataset_3.csv
OTHERREADME.pdf